Early research (Phase 1)Study completedNCT00004047What this trial is testingChemotherapy in Treating Patients Who Have Hematologic CancerWho this might be right forLeukemiaMyelodysplastic Syndromes Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287What this trial is testingCombination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerWho this might be right forBreast CancerKidney CancerLeukemia+3 more Masonic Cancer Center, University of Minnesota 148
Not applicableLooking for participantsNCT07375355What this trial is testingReal-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in ChinaWho this might be right forChronic Myeloid Leukemia in Chronic Phase Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Ended earlyNCT00997243What this trial is testingAzacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Alison Walker 7
Early research (Phase 1)Study completedNCT00030108What this trial is testingIxabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Looking for participantsNCT07033598What this trial is testingPacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic LeukemiaWho this might be right forLeukemia, Myelomonocytic, Chronic Theradex 66
Testing effectiveness (Phase 2)Ended earlyNCT02398825What this trial is testingActivity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to ImatinibWho this might be right forChronic Myeloid LeukemiaChronic PhaseAdults Gruppo Italiano Malattie EMatologiche dell'Adulto 14
Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Early research (Phase 1)Study completedNCT00012376What this trial is testingChemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+15 more National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Study completedNCT00123474What this trial is testingChronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CMLWho this might be right forMyeloid Leukemia, Chronic, Chronic-Phase Bristol-Myers Squibb 724
Testing effectiveness (Phase 2)Study completedNCT00381550What this trial is testing3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00002818What this trial is testingHigh-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more Virginia Commonwealth University 15
Testing effectiveness (Phase 2)Study completedNCT00636909What this trial is testingNonmyeloablative Allo SCT for the Treatment of Hematologic DisordersWho this might be right forAMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more Beth Israel Deaconess Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00002809What this trial is testingBone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Temple University 10
Testing effectiveness (Phase 2)Study completedNCT02793544What this trial is testingHLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation CyclophosphamideWho this might be right forMyelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma+4 more Center for International Blood and Marrow Transplant Research 80
Testing effectiveness (Phase 2)UnknownNCT01690065What this trial is testingNilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AMLWho this might be right forChronic Myeloid Leukemia in Myeloid Blast CrisisUntreated Adult Acute Myeloid Leukemia Ulsan University Hospital 46
Not applicableUnknownNCT05926128What this trial is testingStudy of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forCML Fundaleu 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971What this trial is testingTreatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase InhibitorsWho this might be right forChronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase H. Lee Moffitt Cancer Center and Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT00030394What this trial is testingImatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forChildhood Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia National Cancer Institute (NCI) 64
Not applicableEnded earlyNCT01490983What this trial is testingTelemonitoring Study - for Chronic Myeloid Leukemia (CML)Who this might be right forChronic Myeloid Leukemia Rex Cancer Center, Raleigh, NC 14